Companies similar to INGENERON
Sign up to Download

1-30 of 6,215,419 results

  • celularity.com
  • 24
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent..

Relevance: 32.77209
  • ingeneron.com
  • 2
  • 2
  • 11
InGeneron is a clinical-stage biotechnology company developing cell-based therapies to redefine the standard of care in orthopedics... At InGeneron we use the term "regenerative cell therapy" since there are many different cell types and..

Relevance: 31.425085
  • www.emmecell.com
  • 1
  • 9
Emmetrope Ophthalmics LLC, (aka "Emmecell") is a privately held, clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for the treatment of eye diseases via its exclusive Magnetic Cell Delivery (MCD)..

Relevance: 30.103058
  • www.smart-immune.com
  • 7
  • 20
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next-generation allogeneic T-cell therapies for all. The company was founded..

Relevance: 29.632816
  • www.neuroplast.com
  • 1
  • 1
  • 7
Neuroplast is a clinical stage biotech that develops the stem cell product Neuro-CellsĀ®, a first-in-kind treatment to combat neurodegenerative diseases, for which no effective treatment exists today... Global partner in neuro-regenerative medicine...

Relevance: 29.169699
  • exumabio.com
  • 1
  • 4
  • 13
EXUMA Biotech is a clinical-stage biotechnology company discovering and developing cell and gene therapies for solid & liquid tumors... As part of our commitment to make cell therapies more accessible to earlier lines of therapy, we are developing..

Relevance: 29.10974
  • xnktherapeutics.com
  • 2
  • 19
XNK Therapeutics is a clinical-stage biotechnology company developing unique and individualized natural killer (NK) cell-based cancer therapies. The R&D pipeline targets areas of high unmet medical need within both hematological malignancies and..

Relevance: 29.044708
  • brainstorm-cell.com
  • 1
  • 3
  • 19
BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases.....

Relevance: 28.893461
  • www.repertoire.com
  • 3
  • 1
  • 21
Repertoire Immune Medicines is a biotechnology company dedicated to designing and developing immune medicines based on the power of the human T cell repertoire to address cancer, autoimmune disorders and infectious diseases... Repertoire Immune..

Relevance: 28.858635
  • pharmtechfocus.com
  • 3
  • 18
Quince Therapeutics, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced... BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and..

Relevance: 28.844667
  • alphageneron.com
  • 1
  • 1
  • 7
Alphageneron Pharmaceuticals, Inc., is a privately-held clinical stage biotechnology company, developing targeted natural killer (NK) cell therapies which are supported by Companion Diagnostics. Alphageneron's team is comprised of industry veterans..

Relevance: 28.815598
  • www.scgcell.com
  • 1
  • 12
SCG Cell Therapy Ptd Ltd is a clinical-stage biotechnology company focusing on the development of novel immunotherapies for patients with pathogenic infections and associated cancers... SCG Cell Therapy, our name reflects who we are as an..

Relevance: 28.576815
  • www.acepodia.com
  • 1
  • 1
  • 11
Acepodia was spun-off from Professor Carolyn Bertozzi 's lab who won the 2022 Nobel Prize for Chemistry and founded in 2017 by Dr. Patrick Y. Yang, former EVP of Juno Therapeutics, Roche and Genentech, and by Dr. Sonny Hsiao, UC Berkeley cell..

Relevance: 28.081612
  • coeptistx.com
  • 1
  • 1
  • 13
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), together with its subsidiaries (including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., (collectively "Coeptis"), is a clinical stage biotechnology company developing innovative cell..

Relevance: 28.075567
  • www.immutep.com
  • 6
  • 6
  • 20
Immutep is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. We are pioneers in the understanding and advancement of therapeutics related to Lymphocyte Activation..

Relevance: 27.866104
  • www.tvaxbiomedical.com
  • 2
  • 3
  • 18
TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer... TVAX Biomedical is developing a paradigm-shifting cancer treatment that offers the promise of improved..

Relevance: 27.723473
  • hemostemix.com
  • 1
  • 1
  • 13
Hemostemix is an autologous (patient's own) stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient's blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and..

Relevance: 27.720572
  • www.simnovabio.com
  • 1
  • 3
Simnova is a clinical stage biotech company focusing on the development of cell therapy for cancer patients... Simnova Biotechnology was founded in 2019, which as a subsidiary of Simcere Pharmaceuticals, then spun off into an independent operating..

Relevance: 27.552025
  • www.lindisbiotech.com
  • 1
  • 1
  • 2
Lindis Biotech is a clinical stage bio-pharmaceutical company, committed to develop innovative T- cell engaging trifunctional bispecific antibodies, TriomabĀ® to turn malignant cancers into manageable and possibly curable diseases... Lindis Biotech..

Relevance: 27.44723
  • genebiotherapeutics.com
  • 1
  • 1
  • 4
Gene Biotherapeutics is a publicly-traded, clinical development-stage biotechnology company engaged in the clinical advancement and commercialization of DNA-based biotherapeutics, primarily for the treatment of cardiovascular disease... We are a..

Relevance: 27.236673
  • old.pancella.com
  • 1
  • 1
  • 8
Co-founded in 2015 by Dr. Andras Nagy, PhD, stem cell biologist and Dr. Armand Keating, MD, PhD, clinical scientist and haematologist. The expertise represented by the co-founders were a perfect combination to create a unique conceptual framework for..

Relevance: 27.121506
  • glycomimetics.com
  • 4
  • 2
  • 20
GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases. Our leading researchers leverage their deep understanding of the role that carbohydrates play..

Relevance: 27.073242
  • www.anaptysbio.com
  • 5
  • 2
  • 31
Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics. We are developing immune cell modulators, including two checkpoint agonists for autoimmune and inflammatory disease: rosnilimab, our PD-1..

Relevance: 26.949501
  • www.immuneonco.com
  • 1
  • 2
  • 14
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a joint stock company founded in the Zhangjiang High Tech Park, China (Shanghai) Pilot Free Trade Zone in June, 2015. We are a science-driven biotechnology company dedicated to the development of next-..

Relevance: 26.913149
  • prokidney.com
  • 1
  • 20
ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease, with the potential to preserve kidney function and change..

Relevance: 26.870863
  • www.escapetherapeutics.com
  • 7
  • 3
Escape Therapeutics, Inc. is an early stage biotechnology company focused on accelerating the commercial availability of allogeneic stem cell therapies by solving the key translational hurdle preventing their clinical utility - immune mismatch and..

Relevance: 26.392082
  • cellenkosinc.com
  • 1
  • 1
  • 7
Cellenkos was founded in 2016 with the licensing of a proprietary umbilical cord blood T-Regulatory (Tregs) cell therapy platform from MD Anderson Cancer Center and funded by Golden Meditech Holdings Ltd, a Hong Kong-based integrated healthcare..

Relevance: 26.386513
  • procella.se
  • 1
Based in Stockholm, Procella Therapeutics is an early stage biotechnology company focused on developing cardiac stem cell technology leveraging research from Harvard University and Karolinska Institutet with the aim of treating heart failure...

Relevance: 26.338768
  • cdgti.com
  • 5
  • 7
CDG Therapeutics Inc. was founded at the University of Illinois, Chicago College of Medicine By Drs AM Chakrabarty, Ph.D. and Tapas K. Das Gupta, M.D., Ph.D., D.Sc, and incorporated in the State of Delaware in May 2001, following the discovery that..

Relevance: 25.724571
  • pdcbio.com
  • 3
  • 1
  • 2
PDC Therapeutics is a clinical-stage biotechnology start-up developing smart nanomedicines for targeted therapies via a Polymer Drug Conjugate technology yielding to an optimal therapeutic index... PDC Therapeutics, a clinical-stage biotechnology..

Relevance: 25.518164